Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q3 2023 · 10-Q
Revenue$9.05M$9.05M−5.6% vs Q3 2022 Net Income-$2.26M-$2.26MN/M vs Q3 2022 EPS Diluted-$0.74-$0.74N/M vs Q3 2022 Operating Income-$2,413,672N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,372,873N/M Margins · derivedOperating margin-26.7%−23.3 pt vs Q3 2022
Net margin-25.0%−14.7 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 13, 2023 · 44 d after period end